Reconstitution of Pituitary Specific Transcription
垂体特异性转录的重建
基本信息
- 批准号:7991550
- 负责人:
- 金额:$ 3.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-12-03 至 2010-02-28
- 项目状态:已结题
- 来源:
- 关键词:ActivinsAddressAlternative SplicingAmino AcidsBindingBiochemicalBiologicalCell LineCell OntogenyCell ProliferationCellsComplexCyclic AMPCyclic AMP-Dependent Protein KinasesDNADNA BindingDNA SequenceDataDevelopmentDwarfismEventFamilyFundingGene ExpressionGene TargetingGenesGenetic TranscriptionGoalsGrowthHela CellsHistone AcetylationHistone DeacetylaseHumanMapsMediatingModelingMolecularMolecular BiologyMusNude MicePRL genePhenotypePituitary GlandProtein IsoformsProteinsRNA InterferenceRNA SplicingRecruitment ActivityResearch PersonnelRoleSet proteinSiteSpecificityStructureTestingTranscriptional ActivationTransgenic MiceTransgenic Organismscell typehomeodomainin vivoinsightlactotrophmutantnovelprogramspromoterreconstitutionresponsetranscription factortranscription factor Pit-1transgene expressiontumor growth
项目摘要
The broad mandate of this proposal is to use transgenic, molecular and biochemical approaches to determine the in\
vivo biological effects specific to the Pit-IB isoform with regards to Pit-1-dependent pituitary cell ontogeny and gene
expression, and to define the mechanism that mediates B-isoform-specific transcriptional responses in pituitary cells.
The POU-homeodomain transcription factor, Pit-1, controls the development of somatotroph, lactotroph and thyrotroph
pituitary cell-types, and regulates the cell-specific expression of GH, PRL and TSHB genes. The single Pit-1 gene is
expressed in the Pit-1 lineage as two alternatively-spliced mRNAs, resulting in Pit-1 and Pit-IB proteins. Pit-IB contains
a unique 26 amino-acid (AA) S-domain inserted at AA 48 of Pit-1, precisely in the middle of the transcription activation
domain (TAD). However, Pit-1and Pit-IB share identical structures otherwise. Naturally occurring Pit-1mutations in
mice and humans resulting in heritable dwarfism map to regions common to both Pit-1 and Pit-IB. However, the precise
biological contributions of Pit-IB to pituitary cell-specific ontogeny and gene expression remain unknown. AlthoughPit-
1B has been overlooked after its initial description, during the previous funding period we made important, novel and
unique contributions to our understanding of the precise molecular mechanisms by which the Pit-1 B-domain functions
as a transcription switch motif resulting in B-isoform-specific transcriptional responses. We found that Pit-IB
consistently inhibits PRL, GH and TSHB promoter activities in all pituitary cell lines tested, whereas Pit-IB consistently
activates these same promoters in all nonpituitary cell lines tested. Moreover, Pit-IB inhibited basal, cAMP- and Ras-
stimulated rPRL promoter activity in GH4 pituitary cells. We elucidated mechanism, demonstrating that the B-domain
functions as a pituitary-specific represser motif acting via five hydrophobic amino acids that recruit HDAC activity to
alter the histone acetylation state of the proximal rPRL promoter. Importantly, the B-domain can function as an
autonomous, modular, active and HDAC-dependent represser motif when fused to the Gal4 DBD. Finally, adenoviral
encoded HA-Pit-1B inhibits endogenous PRL and cyclinDI, but activates RB gene expression; and inhibits GH4 cell
proliferation and tumor growth in nude mice, providing evidence of its biological effects. Thus, the Pit-1/Pit-IB pair
provides a prototypical model to study transcription factor isoform-specific functions. We hypothesize that a pituitary-
restricted represser complex that associates with the B-domain dictates Pit-IB isoform-specific transcriptional
responses. A corollary hypothesis is that pituitary cells expressing increased Pit-IB- will have a distinct phenotype. To
address this hypothesis, we propose four Specific Aims: (1) To determine whether HA-Pit-1B- transgene expression
governs the ontogeny and/or expansion of the Pit-1 lineage in transgenic mice. (2) To determine the biological
responses specifically induced by Pit-IB in GH4 cells. (3) To use RNAi to determine the biological role of Pit-IB and
defined co-repressors in mediating B-specific responses. (4) To identify and functionally validate the represser complex
associated with the B-domain. Insights gained from these studies will not only provide a better understanding of Pit-IB
isoform-specific functions, but will also provide a conceptual and experimental framework to study other highly-related
transcription factors that bind to overlapping DMA sites.
该提案的广泛授权是使用转基因,分子和生物化学方法来确定基因
项目成果
期刊论文数量(31)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cyclic adenosine 3',5'-monophosphate activation of the rat prolactin promoter is restricted to the pituitary-specific cell type.
- DOI:10.1210/mend.6.12.1337142
- 发表时间:1992-12
- 期刊:
- 影响因子:0
- 作者:C. Keech;S. M. Jackson;S. Siddiqui;K. Ocran;A. Gutierrez-Hartmann
- 通讯作者:C. Keech;S. M. Jackson;S. Siddiqui;K. Ocran;A. Gutierrez-Hartmann
Selective transcription and DNase I protection of the rat prolactin gene by GH3 pituitary cell-free extracts.
GH3 垂体无细胞提取物对大鼠催乳素基因的选择性转录和 DNase I 保护。
- DOI:10.1073/pnas.84.15.5211
- 发表时间:1987
- 期刊:
- 影响因子:11.1
- 作者:Gutierrez-Hartmann,A;Siddiqui,S;Loukin,S
- 通讯作者:Loukin,S
Lipoprotein lipase gene expression in rat adipocytes is regulated by isoproterenol and insulin through different mechanisms.
大鼠脂肪细胞中脂蛋白脂肪酶基因的表达受异丙肾上腺素和胰岛素通过不同机制的调节。
- DOI:10.1210/mend-4-9-1416
- 发表时间:1990
- 期刊:
- 影响因子:0
- 作者:Raynolds,MV;Awald,PD;Gordon,DF;Gutierrez-Hartmann,A;Rule,DC;Wood,WM;Eckel,RH
- 通讯作者:Eckel,RH
Ras mediates Src but not epidermal growth factor-receptor tyrosine kinase signaling pathways in GH4 neuroendocrine cells.
Ras 介导 GH4 神经内分泌细胞中的 Src,但不介导表皮生长因子受体酪氨酸激酶信号通路。
- DOI:10.1073/pnas.91.18.8612
- 发表时间:1994
- 期刊:
- 影响因子:11.1
- 作者:Pickett,CA;Gutierrez-Hartmann,A
- 通讯作者:Gutierrez-Hartmann,A
Human IL-1 receptor antagonist promoter. Cell type-specific activity and identification of regulatory regions.
人 IL-1 受体拮抗剂启动子。
- DOI:
- 发表时间:1992
- 期刊:
- 影响因子:0
- 作者:SmithJr,MF;Eidlen,D;Brewer,MT;Eisenberg,SP;Arend,WP;Gutierrez-Hartmann,A
- 通讯作者:Gutierrez-Hartmann,A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ARTHUR GUTIERREZ-HARTMANN其他文献
ARTHUR GUTIERREZ-HARTMANN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ARTHUR GUTIERREZ-HARTMANN', 18)}}的其他基金
The Role of ESE-1 in HER2-Positive Breast Cancer
ESE-1 在 HER2 阳性乳腺癌中的作用
- 批准号:
8513937 - 财政年份:2011
- 资助金额:
$ 3.51万 - 项目类别:
The Role of ESE-1 in HER2-Positive Breast Cancer
ESE-1 在 HER2 阳性乳腺癌中的作用
- 批准号:
8710028 - 财政年份:2011
- 资助金额:
$ 3.51万 - 项目类别:
The Role of ESE-1 in HER2-Positive Breast Cancer
ESE-1 在 HER2 阳性乳腺癌中的作用
- 批准号:
8206230 - 财政年份:2011
- 资助金额:
$ 3.51万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 3.51万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 3.51万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 3.51万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 3.51万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 3.51万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 3.51万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 3.51万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 3.51万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 3.51万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 3.51万 - 项目类别:
Research Grant














{{item.name}}会员




